Leukemia Clinical Trials

Showing 2821-2840 of 10,987 trials

A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer

NCT06500026

This trial is a registered phase III, randomized, open-label, multicenter study to evaluate the efficacy and safety of BL-B01D1 in patients with recurrent small cell lung cancer after failure of anti-PD-1/PD-L1 Monoclonal Antibodies and platinum-based chemotherapy.

Small Cell Lung Cancer

Sichuan Baili Pharmaceutical Co., Ltd.714 participantsStarted Aug 2024

Guangzhou, Guangdong, China

Active Not RecruitingPhase 3

AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

NCT05840016

This trial is a Phase III study. All patients are stage IIIB/C (unsuitable for radical therapy) or stage IV squamous non-small cell lung cancer(NSCLC), Eastern Cooperative Oncology Group (ECOG) performance status 0-1. The purpose of this study is to evaluate the efficacy and safety of AK112 combined with chemotherapy versus Tislelizumab combined with chemotherapy in patients with advanced squamous NSCLC.

Advanced Squamous Non Small Cell Lung Cancer

Akeso532 participantsStarted Aug 2023

Shanghai, China

RECRUITING

Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.

NCT06790368

Observational clinical follow-up to evaluate the safety of immunotherapy for the treatment of hymenoptera venom allergy in real-life conditions. It includes the evaluation of controlled and spontaneous stings. This study will be conducted in Spain (multicentric), multicentric and data will be collected prospectively.

Allergy, Insect VenomAllergy Insect StingingInsect Sting Allergy

Inmunotek S.L.80 participantsStarted Jan 2025

Alcorcón, Madrid, Spain • Córdoba, Spain • Guadalajara, Spain

A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer

AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.

Related Searches

CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

Quercus Ilex and Quercus Robur Allergen Extracts Standardisation

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Alectinib Pharmacokinetic in Patients With NSCLC

Exercise as Maintenance Therapy in Advanced Lung Cancer

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Collecting Dietary Information From People Undergoing Cancer Treatment

Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation

Multiomics Tumor Evolution Model of NSCLC

Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas

Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients

Assessing Shoulder Pathways Involving the Cuff

Virtual Reality During Skin Prick Test

A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer

Induction Chemo-Nivo in Unresectable Stage III NSCLC

Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)